J. Lipid Res.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van Vlijmen, B. J. M.
Right arrow Articles by Havekes, L. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Vlijmen, B. J. M.
Right arrow Articles by Havekes, L. M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The Journal of Lipid Research, Vol. 39, 1181-1188, June 1998
Copyright © 1998 by Lipid Research, Inc.


Original Article

Effects of dietary fish oil on serum lipids and VLDL kinetics in hyperlipidemic apolipoprotein E*3-Leiden transgenic mice

Bart J. M. van Vlijmena, Ronald P. Mensinkb, H. Belinda van 't Hofa, Rene F. G. Offermansb, Marten H. Hofkerc, and Louis M. Havekesa,d
a TNO Prevention and Health, Gaubius Laboratory, Leiden
b Department of Human Biology, Maastricht University, Maastricht
c MGC-Department of Human Genetics, Leiden University, Leiden, and Departments of Cardiology and Internal Medicine,
d MGC-Department of Human Genetics, Academic Hospital Leiden, Leiden, The Netherlands

Correspondence to: Ronald P. Mensink.

Studying the effects of dietary fish oil on VLDL metabolism in humans is subject to both large intra- and interindividual variability. In the present study we therefore used hyperlipidemic apolipoprotein (APO) E*3-Leiden mice, which have impaired chylomicron and very low density lipoprotein (VLDL) remnant metabolism, to study the effects of dietary fish oil on serum lipids and VLDL kinetics under highly standardized conditions. For this, female APOE*3-Leiden mice were fed a fat- and cholesterol-containing diet supplemented with either 0, 3 or 6% w/w (i.e. 0, 6, or 12% of total energy) of fish oil. Fish oil-fed mice showed a significant dose-dependent decrease in serum cholesterol (up to -43%) and triglyceride levels (up to -60%), mainly due to a reduction of VLDL (-80%). LDL and HDL cholesterol levels were not affected by fish oil feeding. VLDL-apoB kinetic studies showed that fish oil feeding resulted in a significant 2-fold increase in VLDL-apoB fractional catabolic rate (FCR). Hepatic VLDL-apoB production was, however, not affected by fish oil feeding. VLDL-triglyceride turnover studies revealed that fish oil significantly decreased hepatic VLDL-triglyceride production rate (-60%). A significant increase in VLDL-triglyceride FCR was observed (+70%), which was not related to increased lipolytic activity.

We conclude that APOE*3-Leiden mice are highly responsive to dietary fish oil. The observed strong reduction in serum very low density lipoprotein (VLDL) is primarily due to an effect of fish oil to decrease hepatic VLDL triglyceride production rate and to increase VLDL-apoB fractional catabolic rate.—van Vlijmen, B. J. M., R. P. Mensink, H. B. van 't Hof, R. F. G. Offermans, M. H. Hofker, and L. M. Havekes. Effects of dietary fish oil on serm lipids and VLDL kinetics in hyperlipidemic apolipoprotein E*3-Leiden transgenic mice. J. Lipid Res. 1998. 39: 1181–1188.

Supplementary key words: dietary fish oil, n–3 fatty acids, VLDL metabolism, hyperlipidemia, transgenic mice


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Lipid Res.Home page
C. C. van der Hoogt, W. de Haan, M. Westerterp, M. Hoekstra, G. M. Dallinga-Thie, J. A. Romijn, H. M. G. Princen, J. W. Jukema, L. M. Havekes, and P. C. N. Rensen
Fenofibrate increases HDL-cholesterol by reducing cholesteryl ester transfer protein expression
J. Lipid Res., August 1, 2007; 48(8): 1763 - 1771.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
M.-L. Ricketts, M. V. Boekschoten, A. J. Kreeft, G. J. E. J. Hooiveld, C. J. A. Moen, M. Muller, R. R. Frants, S. Kasanmoentalib, S. M. Post, H. M. G. Princen, et al.
The Cholesterol-Raising Factor from Coffee Beans, Cafestol, as an Agonist Ligand for the Farnesoid and Pregnane X Receptors
Mol. Endocrinol., July 1, 2007; 21(7): 1603 - 1616.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
S. M. S. Espirito Santo, B. J. M. van Vlijmen, R. Buytenhek, W. van Duyvenvoorde, L. M. Havekes, I. Arnault, J. Auger, and H. M. G. Princen
Well-Characterized Garlic-Derived Materials Are Not Hypolipidemic in APOE*3-Leiden Transgenic Mice
J. Nutr., June 1, 2004; 134(6): 1500 - 1503.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
M. Muurling, R. P. Mensink, H. Pijl, J. A. Romijn, L. M. Havekes, and P. J. Voshol
A Fish Oil Diet Does Not Reverse Insulin Resistance despite Decreased Adipose Tissue TNF-{alpha} Protein Concentration in ApoE-3*Leiden Mice
J. Nutr., November 1, 2003; 133(11): 3350 - 3355.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
O. L. Volger, H. van der Boom, E. C. M. de Wit, W. van Duyvenvoorde, G. Hornstra, J. Plat, L. M. Havekes, R. P. Mensink, and H. M. G. Princen
Dietary Plant Stanol Esters Reduce VLDL Cholesterol Secretion and Bile Saturation in Apolipoprotein E*3-Leiden Transgenic Mice
Arterioscler. Thromb. Vasc. Biol., June 1, 2001; 21(6): 1046 - 1052.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. J. M. Delsing, E. H. Offerman, W. van Duyvenvoorde, H. van der Boom, E. C. M. de Wit, M. J. J. Gijbels, A. van der Laarse, J. W. Jukema, L. M. Havekes, and H. M. G. Princen
Acyl-CoA:Cholesterol Acyltransferase Inhibitor Avasimibe Reduces Atherosclerosis in Addition to Its Cholesterol-Lowering Effect in ApoE*3-Leiden Mice
Circulation, April 3, 2001; 103(13): 1778 - 1786.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
H.-C. Hsu, Y.-T. Lee, and M.-F. Chen
Effect of n-3 fatty acids on the composition and binding properties of lipoproteins in hypertriglyceridemic patients1
Am. J. Clinical Nutrition, January 1, 2000; 71(1): 28 - 35.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 1998 by the American Society for Biochemistry and Molecular Biology.